Health Resources and Services Administration; CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment; Meeting, 16581 [06-3163]

Download as PDF Federal Register / Vol. 71, No. 63 / Monday, April 3, 2006 / Notices 16581 Dated: March 22, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6–4774 Filed 3–31–06; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention BILLING CODE 4163–18–P Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Evaluation of Breastfeeding Promotion and Support Programs, Potential Extramural Project (PEP) 2006–R–01 Health Resources and Services Administration; CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment; Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Fragile X Family Needs Assessment, Program Announcement Number PEP 2006–R– 06 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: wwhite on PROD1PC61 with NOTICES Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Fragile X Family Needs Assessment, Program Announcement Number PEP 2006–R–06. Time And Date: 12 p.m.–4 p.m., April 24, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to Fragile X Family Needs Assessment, Program Announcement Number PEP 2006–R–06. Contact Person for More Information: Juliana Cyril, Ph.D., Scientific Review Administrator, Office of Extramural Research, CDC, 1600 Clifton Road, Mailstop D 72, Atlanta, GA 30333, Telephone (404) 639–4639. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 24, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–4776 Filed 3–31–06; 8:45 am] In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Evaluation of Breastfeeding Promotion and Support Programs, PEP 2006– R–01. Time and Date: 8 a.m.–4 p.m., April 27, 2006 (Closed). Place: Centers for Disease Control and Prevention, Global Communications Center, 1600 Clifton Road, NE., Room 254/255 Atlanta, GA 30333, Telephone Number 404– 639–3138. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to: Evaluation of Breastfeeding Promotion and Support Programs, PEP 2006– R–01. For Further Information Contact: Christine Morrison, PhD, Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D–72, Atlanta, GA 30333, Telephone Number 404–639–3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 28, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–4780 Filed 3–31–06; 8:45 am] BILLING CODE 4163–18–P In accordance with section l0(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) announce the following committee meeting. Name: CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment. Times and Dates: 8 a.m.–5 p.m., May 17, 2006, 8 a.m.–12 p.m., May 18, 2006. Place: Sheraton Midtown Atlanta Hotel at Colony Square, 188 14th Street NE., Atlanta, Georgia 30361, Phone 404–892–6000, Fax 404–872–9192 Status: Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people. Purpose: This Committee is charged with advising the Secretary, the Director, CDC and the Administrator, HRSA, regarding activities related to prevention and control of HIV/ AIDS and other STDs, the support of health care services to persons living with HIV/ AIDS, and education of health professionals and the public about HIV/AIDS and other STDs. Matters To Be Discussed: Agenda items include issues pertaining to (1) HPV vaccine (2) CARE Act Reauthorization (3) HIV Counseling and Testing in health care settings. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Paulette Ford-Knights, Public Health Analyst, National Center for HIV, STD, and TB Prevention, 1600 Clifton Road, NE., Mailstop E–07, Atlanta, Georgia 30333. Telephone (404) 639–8008, fax (404) 639–3125, e-mail pbf7@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 27, 2006. Alvin Hall, Director, Management Analysis and Services Office , Centers for Disease Control and Prevention. [FR Doc. 06–3163 Filed 3–31–06; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P VerDate Aug<31>2005 17:30 Mar 31, 2006 Jkt 208001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\03APN1.SGM 03APN1

Agencies

[Federal Register Volume 71, Number 63 (Monday, April 3, 2006)]
[Notices]
[Page 16581]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-3163]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Health Resources and Services Administration; CDC/HRSA Advisory 
Committee on HIV and STD Prevention and Treatment; Meeting

    In accordance with section l0(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) and the Health Resources and Services Administration 
(HRSA) announce the following committee meeting.

    Name: CDC/HRSA Advisory Committee on HIV and STD Prevention and 
Treatment.
    Times and Dates: 8 a.m.-5 p.m., May 17, 2006, 8 a.m.-12 p.m., 
May 18, 2006.
    Place: Sheraton Midtown Atlanta Hotel at Colony Square, 188 14th 
Street NE., Atlanta, Georgia 30361, Phone 404-892-6000, Fax 404-872-
9192
    Status: Open to the public, limited only by the space available. 
The meeting room will accommodate approximately 100 people.
    Purpose: This Committee is charged with advising the Secretary, 
the Director, CDC and the Administrator, HRSA, regarding activities 
related to prevention and control of HIV/AIDS and other STDs, the 
support of health care services to persons living with HIV/AIDS, and 
education of health professionals and the public about HIV/AIDS and 
other STDs.
    Matters To Be Discussed: Agenda items include issues pertaining 
to (1) HPV vaccine (2) CARE Act Reauthorization (3) HIV Counseling 
and Testing in health care settings. Agenda items are subject to 
change as priorities dictate.
    Contact Person for More Information: Paulette Ford-Knights, 
Public Health Analyst, National Center for HIV, STD, and TB 
Prevention, 1600 Clifton Road, NE., Mailstop E-07, Atlanta, Georgia 
30333. Telephone (404) 639-8008, fax (404) 639-3125, e-mail 
pbf7@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: March 27, 2006.
Alvin Hall,
Director, Management Analysis and Services Office , Centers for Disease 
Control and Prevention.
[FR Doc. 06-3163 Filed 3-31-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.